Published in Oncotarget on March 07, 2017
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Hepatocellular carcinoma. Lancet (2012) 18.09
A perspective on cancer cell metastasis. Science (2011) 13.31
Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell (2008) 6.48
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology (2008) 5.53
Cancer stem cells: an evolving concept. Nat Rev Cancer (2012) 4.57
CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest (2010) 3.60
Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer (2010) 2.54
EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget (2015) 1.92
Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology (2013) 1.73
NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab Invest (2009) 1.28
Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis (2008) 1.27
GDF-15 contributes to proliferation and immune escape of malignant gliomas. Clin Cancer Res (2010) 1.20
Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer. Exp Oncol (2013) 1.09
MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. Oncotarget (2015) 1.01
Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma. Curr Cancer Drug Targets (2012) 1.01
Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis. J Cancer Res Clin Oncol (2008) 1.00
Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion. Biochem Pharmacol (2012) 0.98
RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis. Oncotarget (2014) 0.98
Visfatin, a potential biomarker and prognostic factor for endometrial cancer. Gynecol Oncol (2013) 0.98
Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells. BMB Rep (2010) 0.92
GDF15 promotes EMT and metastasis in colorectal cancer. Oncotarget (2015) 0.87
Research progress and prospects of markers for liver cancer stem cells. World J Gastroenterol (2015) 0.86
Growth differentiation factor 15 is induced by hepatitis C virus infection and regulates hepatocellular carcinoma-related genes. PLoS One (2011) 0.83
NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling. Cancer Res (2016) 0.82
Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms. Curr Genomics (2008) 0.82
Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties. Oncotarget (2015) 0.81
The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma. Oncotarget (2016) 0.81
Wnt Signaling in Stem Cells and Tumor Stem Cells. Semin Reprod Med (2015) 0.79
Liver cancer stem cell markers: Progression and therapeutic implications. World J Gastroenterol (2016) 0.78
Abituzumab Targeting of AlphaV-class Integrins Inhibits Prostate Cancer Progression. Mol Cancer Res (2017) 0.75